These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38447854)

  • 1. Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review.
    Kou R; Sadafi SL; Principato R; Anderson LN; Brignardello-Petersen R; Mbuagbaw L
    J Clin Epidemiol; 2024 May; 169():111315. PubMed ID: 38447854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How effects on health equity are assessed in systematic reviews of interventions.
    Welch V; Dewidar O; Tanjong Ghogomu E; Abdisalam S; Al Ameer A; Barbeau VI; Brand K; Kebedom K; Benkhalti M; Kristjansson E; Madani MT; Antequera Martín AM; Mathew CM; McGowan J; McLeod W; Park HA; Petkovic J; Riddle A; Tugwell P; Petticrew M; Trawin J; Wells GA
    Cochrane Database Syst Rev; 2022 Jan; 1(1):MR000028. PubMed ID: 35040487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries.
    Ramke J; Petkovic J; Welch V; Blignault I; Gilbert C; Blanchet K; Christensen R; Zwi AB; Tugwell P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011307. PubMed ID: 29119547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring equity in primary-care-based physical activity interventions using PROGRESS-Plus: a systematic review and evidence synthesis.
    Attwood S; van Sluijs E; Sutton S
    Int J Behav Nutr Phys Act; 2016 May; 13():60. PubMed ID: 27206793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of health equity considerations in cluster and individually randomized trials.
    Petkovic J; Jull J; Yoganathan M; Dewidar O; Baird S; Grimshaw JM; Johansson KA; Kristjansson E; McGowan J; Moher D; Petticrew M; Robberstad B; Shea B; Tugwell P; Volmink J; Wells GA; Whitehead M; Cuervo LG; White H; Taljaard M; Welch V
    Trials; 2020 Apr; 21(1):308. PubMed ID: 32245522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of health equity consideration in masking/PPE policies to contain COVID-19 using PROGRESS-plus framework: a systematic review.
    Chhibber A; Kharat A; Kneale D; Welch V; Bangpan M; Chaiyakunapruk N
    BMC Public Health; 2021 Sep; 21(1):1682. PubMed ID: 34525995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations and guidance in designing equity-relevant clinical trials.
    Mbuagbaw L; Aves T; Shea B; Jull J; Welch V; Taljaard M; Yoganathan M; Greer-Smith R; Wells G; Tugwell P
    Int J Equity Health; 2017 Jun; 16(1):93. PubMed ID: 28583125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the inclusion of equity stratifiers for the measurement of health inequalities within health and social care data collections in Ireland.
    Carroll C; Evans K; Elmusharaf K; O'Donnell P; Dee A; O'Donovan D; Casey M
    BMC Public Health; 2021 Sep; 21(1):1705. PubMed ID: 34538235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases.
    Wang H; Dewidar O; Whittle SL; Ghogomu E; Hazlewood G; Leder K; Mbuagbaw L; Pardo Pardo J; Robinson PC; Buchbinder R; Welch V
    Arthritis Care Res (Hoboken); 2023 May; 75(5):967-974. PubMed ID: 36194078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.
    Nicholls SG; Al-Jaishi AA; Niznick H; Carroll K; Madani MT; Peak KD; Madani L; Nevins P; Adisso L; Li F; Weijer C; Mitchell SL; Welch V; Quiñones AR; Taljaard M
    Alzheimers Dement (Amst); 2023; 15(1):e12392. PubMed ID: 36777091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions on gender equity in the workplace: a scoping review.
    Tricco AC; Parker A; Khan PA; Nincic V; Robson R; MacDonald H; Warren R; Cleary O; Zibrowski E; Baxter N; Burns KEA; Coyle D; Ndjaboue R; Clark JP; Langlois EV; Ahmed SB; Witteman HO; Graham ID; El-Adhami W; Skidmore B; Légaré F; Curran J; Hawker G; Watt J; Bourgeault IL; Leigh JP; Lawford K; Aiken A; McCabe C; Shepperd S; Pattani R; Leon N; Lundine J; Adisso ÉL; Ono S; Rabeneck L; Straus SE
    BMC Med; 2024 Apr; 22(1):149. PubMed ID: 38581003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining and measuring health equity effects in research on task shifting interventions in high-income countries: a systematic review protocol.
    Orkin AM; McArthur A; McDonald A; Mew EJ; Martiniuk A; Buchman DZ; Kouyoumdjian F; Rachlis B; Strike C; Upshur R
    BMJ Open; 2018 Aug; 8(7):e021172. PubMed ID: 30068611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews.
    Aves T; Kredo T; Welch V; Mursleen S; Ross S; Zani B; Motaze NV; Quinlan L; Mbuagbaw L
    J Clin Epidemiol; 2017 Jan; 81():96-100. PubMed ID: 27693883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for identifying and mitigating the equity harms of COVID-19 policy interventions.
    Glover RE; van Schalkwyk MCI; Akl EA; Kristjannson E; Lotfi T; Petkovic J; Petticrew MP; Pottie K; Tugwell P; Welch V
    J Clin Epidemiol; 2020 Dec; 128():35-48. PubMed ID: 32526461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
    Wagner C; Griesel M; Mikolajewska A; Metzendorf MI; Fischer AL; Stegemann M; Spagl M; Nair AA; Daniel J; Fichtner F; Skoetz N
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014963. PubMed ID: 36385229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Is Health Equity Assessed in Cochrane Musculoskeletal Reviews?
    Janusz N; Dewidar O; Dowling S; Wang H; Buchbinder R; Conde M; Ghogomu ET; Maxwell L; Tugwell P; Howe T; Welch V
    J Rheumatol; 2022 Dec; 49(12):1379-1384. PubMed ID: 35970529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axes of social inequities in COVID-19 clinical trials: A systematic review.
    Ponjoan A; Jacques-Aviñó C; Medina-Perucha L; Romero V; Martí-Lluch R; Alves-Cabratosa L; Ramos R; Berenguera A; Garcia-Gil MDM
    Front Public Health; 2023; 11():1069357. PubMed ID: 36891333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.